🇺🇸 UTHR — United Therapeutics Corporation
Salud CompraPrecio actual
601,32 USD
Máx. histórico
601,32
0 días
Split 2:1 del 23/09/2009
Caída desde máximo
En máximo
Rango 52 semanas
430,02 – 609,99
Variación hoy
+0,87%
Cierre anterior
596,13
Rango de hoy
596,14 – 606,16
Volumen hoy
595.233
Peor caída histórica
-93,18%
12/07/2000 → 10/12/2001
Recuperado en 3311 días
Volatilidad anualizada ⓘ
46,95%
- Nombre completo
- United Therapeutics Corporation
- Divisa
- USD
- Mercado
- NasdaqGS
- Sector
- Salud
- Industria
- Drug Manufacturers - Specialty & Generic
- Empleados
- 1.400
- PER ⓘ
- 21,54 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 670,93 USD (puede no estar actualizado)
- Primera cotización
- 17/06/1999
- Precio actualizado
- hace 1 día
United Therapeutics Corporation engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. It offers Tyvaso DPI, an inhaled dry powder via pre-filled and single-use cartridges; Nebulized Tyvaso, an inhaled solution via ultrasonic nebulizer; Remodulin (treprostinil) injection to treat patients with pulmonary arterial hypertension to diminish symptoms associated with exercise; Orenitram, a tablet dosage form of treprostinil, to delay disease progression and improve exercise capacity in PAH patients; and Adcirca, an oral PDE-5 inhibitor to enhance the exercise ability in PAH patients. It also markets and sells Unituxin (dinutuximab) injection, a monoclonal antibody for high-risk neuroblastoma; and Remunity Pump, which contains a pump and separate controller for Remodulin. In addition, it is involved in developing RemunityPRO Pump and Ralinepag for the treatment of PAH;and Nebulized Tyvaso, for the treatment of idiopathic pulmonary fibrosis, as well as xenografts, which are development-stage organ products. Further, it provides preclinical products, including EVLP/CLES, for lung transplant; UKidney, UHeart, UThymoKidney, a development-stage gene-edited porcine kidneys and hearts for xenotransplantation; ULobe, for allogeneic regenerative medicine; ULung, for autologous regenerative medicine; IVIVA Kidney, for autologous regenerative medicine; miroliver, for allogeneic regenerative medicine; and mirokidney, for allogeneic regenerative medicine. It has licensing and collaboration agreements with DEKA Research & Development Corp. to develop a semi-disposable system for the subcutaneous delivery of treprostinil; MannKind Corporation to develop and license treprostinil inhalation powder and the Dreamboat device; and Arena Pharmaceuticals, Inc. to develop Ralinepag. The company was founded in 1996 and is headquartered in Silver Spring, Maryland.
| Fecha | Ratio |
|---|---|
| 23/09/2009 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 09/03/2004 | 11,63 | 11,69 | 11,57 | 11,65 | +0,22% | 1,08% | 1.171.600 |
| 08/03/2004 | 11,73 | 11,77 | 11,62 | 11,63 | -0,30% | 1,24% | 1.015.600 |
| 05/03/2004 | 11,34 | 11,78 | 11,26 | 11,66 | +3,19% | 4,54% | 907.200 |
| 04/03/2004 | 10,97 | 11,35 | 10,86 | 11,30 | +1,62% | 4,42% | 506.600 |
| 03/03/2004 | 10,90 | 11,12 | 10,75 | 11,12 | +2,96% | 3,39% | 442.800 |
| 02/03/2004 | 10,45 | 10,87 | 10,40 | 10,80 | +2,56% | 4,50% | 460.800 |
| 01/03/2004 | 10,60 | 10,73 | 10,32 | 10,53 | -0,66% | 3,87% | 374.800 |
| 27/02/2004 | 10,53 | 10,63 | 10,28 | 10,60 | +0,52% | 3,37% | 557.200 |
| 26/02/2004 | 10,53 | 10,62 | 10,33 | 10,55 | -0,09% | 2,76% | 305.400 |
| 25/02/2004 | 10,60 | 10,63 | 10,44 | 10,56 | -0,66% | 1,75% | 308.600 |
| 24/02/2004 | 10,63 | 10,73 | 10,36 | 10,63 | +3,61% | 3,43% | 771.600 |
| 23/02/2004 | 10,58 | 10,58 | 10,26 | 10,26 | -2,75% | 3,03% | 668.800 |
| 20/02/2004 | 10,71 | 10,71 | 10,51 | 10,55 | -1,49% | 1,82% | 586.600 |
| 19/02/2004 | 10,76 | 10,78 | 10,48 | 10,71 | -0,60% | 2,79% | 702.600 |
| 18/02/2004 | 10,88 | 11,05 | 10,68 | 10,77 | -0,42% | 3,45% | 378.600 |
| 17/02/2004 | 10,79 | 10,96 | 10,74 | 10,82 | -0,14% | 1,99% | 346.000 |
| 13/02/2004 | 10,98 | 11,05 | 10,78 | 10,83 | -1,41% | 2,50% | 212.800 |
| 12/02/2004 | 11,20 | 11,27 | 10,99 | 10,99 | -2,40% | 2,54% | 460.000 |
| 11/02/2004 | 11,09 | 11,27 | 11,07 | 11,26 | +0,72% | 1,80% | 178.400 |
| 10/02/2004 | 10,99 | 11,18 | 10,88 | 11,18 | +2,57% | 2,73% | 336.400 |
| 09/02/2004 | 10,88 | 10,92 | 10,79 | 10,90 | +0,65% | 1,24% | 697.600 |
| 06/02/2004 | 10,58 | 11,06 | 10,56 | 10,83 | +3,10% | 4,77% | 449.200 |
| 05/02/2004 | 10,88 | 10,94 | 10,50 | 10,50 | -3,67% | 4,05% | 858.200 |
| 04/02/2004 | 11,22 | 11,25 | 10,84 | 10,90 | -2,98% | 3,65% | 775.600 |
| 03/02/2004 | 11,23 | 11,52 | 11,04 | 11,24 | +0,36% | 4,28% | 808.200 |
| 02/02/2004 | 10,69 | 11,22 | 10,53 | 11,20 | +7,39% | 6,50% | 916.000 |
| 30/01/2004 | 10,70 | 10,83 | 10,43 | 10,43 | -2,48% | 3,79% | 797.200 |
| 29/01/2004 | 10,95 | 11,39 | 10,51 | 10,69 | -2,33% | 7,99% | 1.165.600 |
| 28/01/2004 | 11,25 | 11,47 | 10,94 | 10,95 | -3,27% | 4,71% | 623.600 |
| 27/01/2004 | 11,65 | 11,77 | 11,19 | 11,32 | -3,25% | 4,98% | 1.184.600 |